Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia
Clinical trial NCT00154349 · COMPLETED
Trial details
- NCT number
- NCT00154349
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2007-02-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.